Sanofi Settles SEC's International Bribery Claims For $25M
French pharmaceutical company Sanofi SA agreed Tuesday to pay $25.2 million to end the U.S. Securities and Exchange Commission's investigation into alleged bribes by a number of the company's international subsidiaries...To view the full article, register now.
Already a subscriber? Click here to view full article